Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| HGS-S246 | Rabbit | Recombinant Monoclonal Anti-CD44 Antibody, Rabbit (5G3) | |||
| PG1-H5255 | Human | Human CD44 Protein, Fc Tag (HPLC-verified) |  |
|
|
| CD4-H5226 | Human | Human CD44 Protein, His Tag |  |
|
|
Immobilized Human CD44, His Tag (Cat. No. CD4-H5226) at 5 μg/mL (100 μL/well) can bind Hyaluronan biotin sodium salt with a linear range of 39-156 ng/mL (Routinely tested).
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| BGC-0228 | BGC-0228 | Phase 1 Clinical | Brightgene Bio-Medical Technology Co Ltd | Solid tumours | Details |
| Bivatuzumab | BIWA-4; anti-CD44; anti-CD44 monoclonals | C.H. Boehringer Sohn Ag & Co. Kg | Details | ||
| CA-102N | CA-102N | Biobud | Details | ||
| AMC-303 | AMC-303; HP-558 | Phase 1 Clinical | Amcure Gmbh | Solid tumours; Esophageal Squamous Cell Carcinoma | Details |
| CD44v6-specific CAR gene-engineered T cell therapy (Shenzhen Geno-Immune Medical Institute) | 4SCAR-CD44v6 | Phase 2 Clinical | Shenzhen Geno-Immune Medical Institute | Neoplasms | Details |
| Multiple 4SCAR-T Cell Therapy (Shenzhen Geno-Immune Medical Institute) | Phase 2 Clinical | Shenzhen Geno-Immune Medical Institute | Breast Neoplasms | Details | |
| Clodronic acid/Hyaluronic acid | Phase 1 Clinical | Abiogen Pharma Spa | Osteoarthritis | Details | |
| Hydrogen peroxide/Hyaluronic acid | BMG-0703 | Phase 3 Clinical | University Of Milan | Bruxism; Gingival Hemorrhage; Gingivitis; Surgical Wound; Periodontitis | Details |
| Hyaluronic acid/Fluorouracil | HA-5FU; HA-5-fluorouracil; Hyaluronic acid-5-fluorouracil complex; Hyaluronan acid-5-fluorouracil complex | Phase 2 Clinical | Monash University, Alchemia Ltd | Colorectal Neoplasms | Details |
| Hyaluronic acid inhalation (Actelion Pharmaceuticals) | ETX-100; CTX-100 | Actelion Pharmaceuticals Ltd | Details | ||
| Paclitaxel/Hyaluronic acid | Phase 3 Clinical | Fidia Pharma | Carcinoma, Papillary; Urinary Bladder Neoplasms | Details |
This web search service is supported by Google Inc.
A-Z
